Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.
Saved in:
| Title: | Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects. |
|---|---|
| Authors: | Aicher HD; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland., Mueller MJ; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.; Department of Health Science and Technology, ETH, Zurich, Switzerland., Dornbierer DA; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Department of Forensic Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Suay D; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; MoMiLab, IMT School for Advanced Studies Luca, Lucca, Italy., Elsner C; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Wicki I; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Meling D; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychosomatic Medicine and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Caflisch L; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Hempe A; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Biopsychology, Department of Psychology, TUD Dresden University of Technology, Dresden, Germany., Steinhart C; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Mueller J; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Von Rotz R; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Kleim B; Department of Psychology, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.; Experimental Psychopathology and Psychotherapy, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Scheidegger M; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland. |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2024 Jan 08; Vol. 14, pp. 1302559. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38264636 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aicher+HD%22">Aicher HD</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mueller+MJ%22">Mueller MJ</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.; Department of Health Science and Technology, ETH, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dornbierer+DA%22">Dornbierer DA</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Department of Forensic Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Suay+D%22">Suay D</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; MoMiLab, IMT School for Advanced Studies Luca, Lucca, Italy.<br /><searchLink fieldCode="AU" term="%22Elsner+C%22">Elsner C</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wicki+I%22">Wicki I</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Meling+D%22">Meling D</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychosomatic Medicine and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Caflisch+L%22">Caflisch L</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hempe+A%22">Hempe A</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Biopsychology, Department of Psychology, TUD Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Steinhart+C%22">Steinhart C</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mueller+J%22">Mueller J</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Von+Rotz+R%22">Von Rotz R</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kleim+B%22">Kleim B</searchLink>; Department of Psychology, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.; Experimental Psychopathology and Psychotherapy, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scheidegger+M%22">Scheidegger M</searchLink>; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101545006%22">Frontiers in psychiatry</searchLink> [Front Psychiatry] 2024 Jan 08; Vol. 14, pp. 1302559. <i>Date of Electronic Publication: </i>2024 Jan 08 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101545006 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-0640 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216640640%22">16640640 </searchLink><i>NLM ISO Abbreviation: </i>Front Psychiatry <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38264636 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fpsyt.2023.1302559 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1302559 Titles: – TitleFull: Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aicher HD – PersonEntity: Name: NameFull: Mueller MJ – PersonEntity: Name: NameFull: Dornbierer DA – PersonEntity: Name: NameFull: Suay D – PersonEntity: Name: NameFull: Elsner C – PersonEntity: Name: NameFull: Wicki I – PersonEntity: Name: NameFull: Meling D – PersonEntity: Name: NameFull: Caflisch L – PersonEntity: Name: NameFull: Hempe A – PersonEntity: Name: NameFull: Steinhart C – PersonEntity: Name: NameFull: Mueller J – PersonEntity: Name: NameFull: Von Rotz R – PersonEntity: Name: NameFull: Kleim B – PersonEntity: Name: NameFull: Scheidegger M IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 01 Text: 2024 Jan 08 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 1664-0640 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in psychiatry Type: main |
| ResultId | 1 |
